Conference
The role of FSH in castration-induced adipogenesis and cardiovascular diseases: Highlighting differences between orchiectomy, GNRH agonists, and antagonists.
Abstract
191
Background: Androgen deprivation therapy (ADT) is associated with weight gain and development of the metabolic syndrome (MS). Different modes of ADT can achieve castration but with different affects on serum FSH levels. Inspired by the observation that adiposity accompanies the incremental increase in serum follicle stimulating hormone (FSH) levels in menopause, we hypothesized that gonadotrophin-releasing hormone (GnRH) …
Authors
Pinthus JH; Hopmans S; Werstuck G; Duivenvoorden WC
Volume
32
Pagination
pp. 191-191
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 1, 2014
DOI
10.1200/jco.2014.32.4_suppl.191
Conference proceedings
Journal of Clinical Oncology
Issue
4_suppl
ISSN
0732-183X